Wright Investors Service Comprehensive Report for CTI BioPharma Corp
25 Sep 2016
Available for Immediate Download
Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio tables (Accounting, Asset Utilization, Employee Efficiency, Fixed Charges Coverage, Leverage Analysis, Liquidity Analysis, Per-share Data and Profitability Analysis) and proprietary Wright Quality RatingÂ® analyses tables. The Wright Quality Rating measures the liquidity of the stock and the financial strength, profitability and corporate growth characteristics of CTI BioPharma Corp A textual review of the financial results of CTI BioPharma Corp versus Reliv' International, Inc., Adamas Pharmaceuticals Inc and Orexigen Therapeutics Inc is includedrepo. The comparative analysis,of these companies,compares Sales, Company Valuations and Financial Position. Also included for CTI BioPharma Corp are: Company Description, Recent Stock Performance, Profitability Analysis, Dividend Analysis, and key data items. Additional research for CTI BioPharma Corp includes tables with up to 10-years of history of computed ratios, sales, earnings, and security prices. The companyâ€™s financial results are compared in a series of reports (i.e. financial statements, sales, key ratios, etc.) to global industry averages.